Genvira Biosciences Inc.

About Genvira Biosciences Inc.

Genvira Biosciences, located in Ottawa, Canada, builds innovative viral-based biotherapeutics. The company specializes in viral vector engineering for applications in cancer immunotherapy, gene therapy, and vaccines. They design, construct, and characterize customized DNA and RNA viruses with high stability and efficiency, serving Canadian and international clients at various stages of clinical development.

Products & Services

Viral Engineering:Design, construction, and characterization of customized non-pathogenic RNA/DNA viruses with long-term stability, low immunogenicity, and high transduction efficiency for cancer immunotherapy, gene therapy, and vaccines.

Cancer Immunotherapy & Gene Therapy:Bioengineered DNA viruses like Adeno-associated viruses (AAVs) and Myxoma viruses to deliver genes into target cells for treating diseases such as cancers and retinal disorders, including functional bioassays for potency and immunogenicity testing.

Vaccines:Creation of vaccines for research and clinical needs, including safe SARS-CoV-2 pseudoviruses for in vitro and in vivo studies without requiring BSL3 laboratories.

SARS-CoV-2 Spike VSV-based Pseudovirus:A specific pseudovirus product for research purposes, safe for studies due to non-replication.

Services:Comprehensive services including cell and viral engineering, end-to-end engineering, formulation for viral stability, assay development, animal model studies, process development, small-scale production, FDA regulatory filings, GLP-like studies, and scalability consultation.

Specialties

Viral Vector Engineering Cancer Immunotherapy Gene Therapy Vaccines Cell Engineering Assay Development Regulatory Filings

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2000000 MR: - FA: £1.2 million ($2.0 million) FAN: 2000000	D: 2025-07-31 FD: 2025-07-31	4 investors

Grant Latest

2025-07-31

$2.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News